Korinna Karampampa

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Acute Lymphoblastic Leukemia

Multiple Sclerosis

Top Venues

Journal of medical economics

Multiple sclerosis journal - experimental, translational and clinical

The European journal of health economics : HEPAC : health economics in prevention and care

This page only lists publications with an associated author ORCID identifier.

Publications

Korinna Karampampa, Hanna Gyllensten, Emilie Friberg, Chantelle Murley, Andrius Kavaliunas, Jan A Hillert, Tomas Olsson, Kristina Alexanderson
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. BMJ open 13 (5) (2023)
Korinna Karampampa, Hanna Gyllensten, Emilie Friberg, Chantelle Murley, Andrius Kavaliunas, Jan A Hillert, Tomas Olsson, Kristina Alexanderson
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. BMJ open 13 (5) (2023)
Korinna Karampampa, Hanna Gyllensten, Emilie Friberg, Chantelle Murley, Andrius Kavaliunas, Jan A Hillert, Tomas Olsson, Kristina Alexanderson
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. BMJ open 13 (5) (2023)
Korinna Karampampa, Wenjie Zhang, Meena Venkatachalam, Francois-Emery Cotté, Devender Dhanda
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France. Journal of medical economics 26 (1) (2023)
Korinna Karampampa, Wenjie Zhang, Meena Venkatachalam, Francois-Emery Cotté, Devender Dhanda
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France. Journal of medical economics 26 (1) (2023)
Korinna Karampampa, Wenjie Zhang, Meena Venkatachalam, Francois-Emery Cotté, Devender Dhanda
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France. Journal of medical economics (2023)
Korinna Karampampa, Hanna Gyllensten, Emilie Friberg, Chantelle Murley, Andrius Kavaliunas, Jan A Hillert, Tomas Olsson, Kristina Alexanderson
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. BMJ open 13 (5) (2023)
Korinna Karampampa, Hanna Gyllensten, Chantelle Murley, Kristina Alexanderson, Andrius Kavaliunas, Tomas Olsson, Ali Manouchehrinia, Jan Hillert, Emilie Friberg
Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden. Multiple sclerosis journal - experimental, translational and clinical 8 (2) (2022)
Chantelle Murley, Petter Tinghög, Fitsum Sebsibe Teni, Alejandra Machado, Kristina Alexanderson, Jan A Hillert, Korinna Karampampa, Emilie Friberg
Excess costs of multiple sclerosis: a register-based study in Sweden. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Chantelle Murley, Petter Tinghög, Kristina Alexanderson, Jan A Hillert, Emilie Friberg, Korinna Karampampa
Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group. PharmacoEconomics 39 (7) (2021)
Amanda Sundberg, Anna Carin Wahlberg, Niklas Zethraeus, Korinna Karampampa
Observational study of the implementation of telephone advice nursing in Sweden: did callers follow recommendations and did the rate of healthcare visits change? BMJ open 11 (8) (2021)
Greta Bütepage, Ahmed Esawi, Kristina Alexanderson, Emilie Friberg, Chantelle Murley, Jan Hillert, Korinna Karampampa
Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden. Multiple sclerosis journal - experimental, translational and clinical 6 (4) (2020)